Targeting mTOR for the treatment of AML. New agents and new directions

Despite recent advances in the field, the treatment of patients with acute myeloid leukemia (AML) remains challenging and difficult. Although chemotherapeutic agents induce remissions in a large number of patients, many of them eventually relapse and die. A major goal for the development of new appr...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Altman, Jessica K., Sassano, Antonella, Platanias, Leonidas C.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2011
Konular:
Research Perspectives
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3248202/
https://ncbi.nlm.nih.gov/pubmed/21680954
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller